Socioeconomic status linked with outcomes and survival in patients treated for non-small cell lung cancer medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
E-Mail
Boston, MA (April 30, 2021) - A new study, presented today at the AATS 101st Annual Meeting, shows significant reduction in post-operative use of Schedule II opioids for pain management following robotic surgery. To address the on-going issues of opioid overuse and abuse, the study aimed to examine the use of painkillers in Enhanced Recovery After Thoracic Surgery (ERATS) protocols and determine the impact of alternative pain management approaches on clinical outcomes.
An Institutional Review Board-approved retrospective analysis of a prospectively maintained thoracic surgery database was performed on all patients undergoing elective robotic thoracic procedures from 7/1/2019 to 9/14/2020. The main pain management component of ERATS included opioid-sparing analgesics, infiltration of liposomal bupivacaine (a long-acting local anesthetic) 1:1 v/v dilution with normal saline to 9 intercostal spaces as intercostal nerve blocks and to surgical wounds as local and regional anal